CSIMarket
 
Pacira Biosciences inc   (NASDAQ: PCRX)
 

Pacira Biosciences Inc's Suppliers Performance

PCRX's Supply Chain




 
PCRX Costs vs Sales of Suppliers Growth Pacira Biosciences Inc recorded an increase in cost of sales by 8.07 % year on year, sequentially cost of sales grew by 21.29 % in Q2.

More on PCRX Suppliers



Pacira Biosciences Inc recorded increase in cost of sales by 8.07 % year on year, sequentially cost of sales grew by 21.29 % in Q2.

More on PCRX Suppliers




Pacira Biosciences Inc's Comment on Supply Chain


Pacira BioSciences, Inc. sources raw materials and components from third-party suppliers to manufacture its products EXPAREL, ZILRETTA, and iovera°. While alternative suppliers are generally available, switching suppliers may cause delays. The company manages supply risks by maintaining adequate inventory and qualifying additional sources. Manufacturing and testing are conducted by Pacira and its partners under current Good Manufacturing Practice (CGMP) standards at facilities including an 84,000 square-foot EXPAREL manufacturing site and a 90,000 square-foot mixed-use research, development, and manufacturing facility located at the Science Center Campus. A 21,000 square-foot CGMP warehouse supports storage requirements. Distribution of Pacira's preservative-free multi-dose vial (pMVL) products requires cold-chain logistics with validated temperature monitoring. Pacira has a Strategic Co-Production Agreement with Thermo Fisher Scientific Pharma Services for the manufacturing and supply of EXPAREL.

Pacira Biosciences Inc's Comment on Supply Chain


Pacira BioSciences, Inc. sources raw materials and components from third-party suppliers to manufacture its products EXPAREL, ZILRETTA, and iovera°. While alternative suppliers are generally available, switching suppliers may cause delays. The company manages supply risks by maintaining adequate inventory and qualifying additional sources. Manufacturing and testing are conducted by Pacira and its partners under current Good Manufacturing Practice (CGMP) standards at facilities including an 84,000 square-foot EXPAREL manufacturing site and a 90,000 square-foot mixed-use research, development, and manufacturing facility located at the Science Center Campus. A 21,000 square-foot CGMP warehouse supports storage requirements. Distribution of Pacira's preservative-free multi-dose vial (pMVL) products requires cold-chain logistics with validated temperature monitoring. Pacira has a Strategic Co-Production Agreement with Thermo Fisher Scientific Pharma Services for the manufacturing and supply of EXPAREL.







PCRX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Pacira Biosciences inc 1,001.46 746.16 14.64 829
SUBTOTAL 0.00 0.00 0.00 -


Sources: Pacira Biosciences inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Pacira Biosciences inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.